India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...
Bajaj Finserv Ltd. has garnered multiple buy recommendations from various analysts, all predicting an upward movement in the ...
To make cancer care more affordable in price-sensitive India, Mazumdar-Shaw said, the government must also cut import duties ...
The Nity50 opened with a significant gap up of 102 points at 23,306.20. However, sellers intervened and pulled the index down ...
CCI fines Goldman Sachs for undisclosed investment in Biocon, highlighting need for compliance with competition laws in ...
The market may extend its upward journey, but sustainability is the key to watch, given the elevated volatility. Below are ...
Here's a list of buy/sell recommendations for today from three analysts: Ankush Bajaj, Raja Venkatraman, and MarketSmith ...
Biocon's chairperson urges India's government to exempt cancer and chronic disease drugs from taxes to alleviate patient ...
This article summarizes current health news, highlighting issues like healthcare gaps in rural China, EU's proposed ban on ...
Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and ...